The clinical course of CLL is very heterogeneous, starting from a reasonably asymptomatic ailment which could even regress spontaneously into a progressive illness that at some point results in the affected person’s death, so there has always been remarkable desire in analyzing the prognosis of specific sufferers. Despite the fact that quite a fe